References
Canadian National Breast Screening Study.Can Med Assoc J 1992; 147: 1459–1488.
Kopans DB. The accuracy of mammographic interpretation.N Engl J Med 1994; 331: 1521.
Mittra I. Breast screening: the case for physical examination without mammography.Lancet 1994; 343: 342–344.
JAMA 1993; 269: 2616–2617.
Conant EF, Philadelphia PA, Ehrlich SM, Topham A, Finkel GC, Schwartz GF, Feig SA. Age analysis of 3,159 consecutive nonpalpable and palpable breast lesions.Radiology 1994; 193 (P): 239.
Scheidhauer K, Scharl A, Pietrzyk U, Wagner R, Schomacker K, Schicha H. Qualitative FDG-PET zum Staging primärer Mamma-Tumoren.Nukl Med 1995; 34: A149.
Avril N, Janicke F, Dose J, Bense S, Ziegler S, Zinke M, Laubenbacher C, Romer W, Hertz M, Schwaiger M. PET imaging of breast tumors: Munich experience.J Nucl Med 1995; 36: 82P.
Avril N, Janicke F, Dose J, Bense S, Ziegler S, Zinke M, Romer W Weber W, Herz M, Schwaiger M. PET evaluation of axillary lymph node involvement in breast cancer patients.J Nucl Med 1995; 36: 82P.
Khalkhali I, Cutrone J, Mena 1, Diggles L, Khalkhali S, Venegas R, Klein, S. The usefulness of scintimammography (SMM) in patients (PTS) with dense breasts on mammogram (MAMM).J Nucl Med 1995; 36: 52P.
Jochelson MS, Waxman A, Nagaraj N, Phillips E, Yadegar J. Tc-99m methoxy isobutyl isonitrile breast imaging in conjunction with mammography: review of 350 cases.Radiology 1994; 193 (P): 158.
Spieth M, Vasinrapee P, Evans T, Wong D, Wade W, Disher A. SPECT scintimammography for lymphadenopathy: preliminary clinical findings.J Nucl Med 1995; 36: 52P.
Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J. 99m-Tc-sestamibi prone scintimammography in detection of primary breast cancer and axillary lymph node involvement.J Nucl Med 1995; 36: 52P.
Piccolo S, Lastoria S, Mainolfi C, Muto P, Bazzicalupo L, Salvatore M. Technetium-99m-methylene diphospbonate scintimammography to image primary breast cancer.J Nucl Med 1995; 36: 718–724.
Piccolo S, Lastoria S, Mainolfi C, Wang H, Muto P, Bazzicalupo L, Salvatore M. Primary breast cancer detection by SMM with99mTc-MDP: comparison with mammographic and histological results in 400 patients.J Nucl Med 1995; 36: 83P.
Lastoria S, Piccolo S, Varrella P, Acampa W, Mainolfi C, Vergara E, Wang H, Muto P, Salvatore M. Comparative results of Tc-99m MIBI and Tc-99m MDP scintimammography in patients with breast abnormalities.J Nucl Med 1995; 36: 51P.
Sehweil AM, McKillop JH, Milroy R, Sayet MA, Ziada G, Banham SW, Davidson KG, Ragib A, Omar YT, Abdel-Dayem HM.201Tl scintigraphy in the staging of lung, breast cancer and lymphoma.Nucl Med Commun 1990; 11: 263–269.
Waxman AD, Ramanna L, Memsic LD, Foster CE, Silberman AW, Gleischman SH, Brenner RJ, Brachman MB, Kuhar CJ, Yadegar J. Thallium scintigraphy in the evaluation of mass abnormalities of the breast.J Nucl Med 1993; 34: 18–23.
Lee VW, Sax EJ, McAneny DB, Pollack S, Blanchard RA, Beazley RM, Kavanah MT, Ward RJ. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer.J Nucl Med 1993; 34: 2095–2100.
Bardfeld PA, Cancroft ET, Atkins HL. Usefulness of Tl-201 scintigraphy in breast cancer diagnosis.Radiology 1994; 193(P): 300.
Eijck CHJ van, Krenning EP, Bootsma A, Oei HY, Pel R van, Lindemans J, Jeekel J, Reubi JC, Lamberts SWK. Somatostatin-receptor scintigraphy in primary breast cancer.Lancet 1994; 343: 640–643.
McEwan AJB, Akram I, Boniface G, Golberg L, McQuarrie SA, Golberg K, Amyotte G, Hornig B, Noujaim AA, MacLean GD. Tc-99m MAb 170H.82 in the evaluation of locoregional disease in patients with breast cancer.J Nucl Med 1994; 21: S15.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ell, P.J. Keeping abreast of time. Eur J Nucl Med 22, 967–969 (1995). https://doi.org/10.1007/BF00808406
Issue Date:
DOI: https://doi.org/10.1007/BF00808406